更正：阿托伐他汀、氯沙坦和卡托普利导致冠状动脉疾病和高血压中转化生长因子-β上调及白细胞介素-6下调。
Correction: Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.
作者信息
Sepehri Zahra, Masoumi Mohammad, Ebrahimi Nazanin, Kiani Zohre, Nasiri Ali Akbar, Kohan Farhad, Fathollahi Mahmood Sheikh, Arababadi Mohammad Kazemi, Asadikaram Gholamreza
出版信息
PLoS One. 2017 Feb 13;12(2):e0172404. doi: 10.1371/journal.pone.0172404. eCollection 2017.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0168312.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0168312。]
相似文献
1
Correction: Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.更正：阿托伐他汀、氯沙坦和卡托普利导致冠状动脉疾病和高血压中转化生长因子-β上调及白细胞介素-6下调。
PLoS One. 2017 Feb 13;12(2):e0172404. doi: 10.1371/journal.pone.0172404. eCollection 2017.
2
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.阿托伐他汀、氯沙坦和卡托普利可导致冠状动脉疾病和高血压患者体内转化生长因子-β上调及白细胞介素-6下调。
PLoS One. 2016 Dec 29;11(12):e0168312. doi: 10.1371/journal.pone.0168312. eCollection 2016.
3
Atorvastatin, losartan and captopril may upregulate IL-22 in hypertension and coronary artery disease; the role of gene polymorphism.阿托伐他汀、氯沙坦和卡托普利可能上调高血压和冠状动脉疾病患者的白细胞介素-22；基因多态性的作用。
Life Sci. 2018 Aug 15;207:525-531. doi: 10.1016/j.lfs.2018.07.005. Epub 2018 Jul 5.
4
Renin angiotensin system blockade ameliorates lead nephropathy.肾素血管紧张素系统阻断可改善铅肾病。
Biochem Biophys Res Commun. 2013 Aug 23;438(2):359-63. doi: 10.1016/j.bbrc.2013.07.076. Epub 2013 Jul 26.
5
Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.更正：维拉帕米缓释片和阿替洛尔对冠心病高血压患者24小时血压和心率的影响：一项维拉帕米缓释片-群多普利动态监测国际子研究。
PLoS One. 2016 Jun 3;11(6):e0157212. doi: 10.1371/journal.pone.0157212. eCollection 2016.
6
Correction: Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.更正：阿托伐他汀通过干扰胶原代谢改善心肌梗死后心室重构。
PLoS One. 2017 Feb 14;12(2):e0172453. doi: 10.1371/journal.pone.0172453. eCollection 2017.
7
Losartan renography for the detection of renal artery stenosis: comparison with captopril renography and evaluation of dose and timing.氯沙坦肾图用于检测肾动脉狭窄：与卡托普利肾图的比较及剂量和时间的评估
Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1064-74. doi: 10.1007/s00259-005-1789-9. Epub 2005 May 5.
8
Losartan and captopril treatment rescue normal thrombus formation in microfibril associated glycoprotein-1 (MAGP1) deficient mice.氯沙坦和卡托普利治疗可挽救微原纤维相关糖蛋白-1（MAGP1）缺陷小鼠的正常血栓形成。
Thromb Res. 2016 Feb;138:7-15. doi: 10.1016/j.thromres.2015.12.004. Epub 2015 Dec 10.
9
Correction: The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells.更正：氯沙坦对人小梁网细胞巨细胞病毒感染的影响。
PLoS One. 2019 Aug 22;14(8):e0221693. doi: 10.1371/journal.pone.0221693. eCollection 2019.
10
Correction: Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study).更正：肥胖和代谢性疾病对冠状动脉疾病患者颈动脉粥样硬化的影响（CordioPrev研究）。
PLoS One. 2016 Jun 9;11(6):e0157213. doi: 10.1371/journal.pone.0157213. eCollection 2016.
引用本文的文献
1
Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization.小载脂蛋白(a)异构体可能预测外周动脉血运重建后的原发性通畅情况。
JVS Vasc Sci. 2024 Jun 11;5:100211. doi: 10.1016/j.jvssci.2024.100211. eCollection 2024.
本文引用的文献
1
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.阿托伐他汀、氯沙坦和卡托普利可导致冠状动脉疾病和高血压患者体内转化生长因子-β上调及白细胞介素-6下调。
PLoS One. 2016 Dec 29;11(12):e0168312. doi: 10.1371/journal.pone.0168312. eCollection 2016.
Zotero 插件